FUS-related proteinopathies: lessons from animal models

Nicholas A Lanson1, Udai Bhan Pandey

  • 1Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA 70112-2223, USA.

Brain Research
|February 21, 2012
PubMed

Insights

Mutations in FUS and TDP-43 are linked to neurodegenerative diseases like ALS and FTLD. This review explores how FUS protein dysfunction, particularly RNA-mediated effects, contributes to these conditions.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are linked to mutations in FUS and TDP-43.
  • RNA-mediated proteinopathy is an emerging mechanism in neurodegenerative disorders.
  • FUS and TDP-43 are structurally and functionally similar DNA/RNA binding proteins.

Purpose of the Study:

  • To review recent advances in understanding FUS protein functions.
  • To discuss insights from FUS animal models regarding ALS pathogenesis.
  • To explore how ALS-linked mutations affect FUS functions.

Main Methods:

  • Literature review of FUS functions and related research.
  • Analysis of findings from FUS animal models.
  • Discussion of molecular mechanisms in ALS pathogenesis.

Main Results:

  • FUS plays a role in RNA metabolism, including splicing and microRNA biogenesis.
  • ALS-linked mutations are suspected to perturb normal FUS functions.
  • FUS animal models offer key insights into disease mechanisms.

Conclusions:

  • Understanding FUS protein function is crucial for elucidating ALS pathogenesis.
  • RNA-mediated mechanisms are increasingly recognized in neurodegeneration.
  • Further research into FUS dysfunction may reveal therapeutic targets for ALS and FTLD.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...